120 related articles for article (PubMed ID: 6703723)
1. [Phase II study of mitoxantrone for acute leukemia].
Oguma S; Tatsumi Y; Hirayama F; Tani Y; Kubota Y; Kanakura Y; Ueda T; Nakamura H; Shibata H; Masaoka T
Gan To Kagaku Ryoho; 1984 Mar; 11(3):497-501. PubMed ID: 6703723
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study of mitoxantrone in patients with acute leukemia].
Kimura K; Yoshikawa S; Yoshikawa H; Yamada K; Hirano M; Ikeda Y; Ohta K; Ohara K; Kobayashi M; Shirakawa S
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2573-80. PubMed ID: 3740858
[TBL] [Abstract][Full Text] [Related]
3. Phase I-II trial of mitoxantrone in acute leukemia.
Arlin ZA; Silver R; Cassileth P; Armentrout S; Gams R; Daghestani A; Coleman M; Schoch I; Dukart G
Cancer Treat Rep; 1985 Jan; 69(1):61-4. PubMed ID: 3855386
[TBL] [Abstract][Full Text] [Related]
4. [A phase II study of mitoxantrone in acute leukemia. Hanshin Cooperative Study Group of Hematological Disorders].
Masaoka T; Oguma S; Shibata H; Nagai K; Horiuchi A; Kitani T; Yonezawa T; Kawagoe H; Yasunaga K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2793-9. PubMed ID: 3753025
[TBL] [Abstract][Full Text] [Related]
5. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone in patients with acute leukemia in relapse.
Paciucci PA; Ohnuma T; Cuttner J; Silver RT; Holland JF
Cancer Res; 1983 Aug; 43(8):3919-22. PubMed ID: 6861154
[TBL] [Abstract][Full Text] [Related]
7. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
Sampi K; Kaneko Y; Maseki N; Kumai R; Sakurai M; Hattori M
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1453-7. PubMed ID: 4015120
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of mitoxantrone in refractory acute leukemia.
Estey EH; Keating MJ; McCredie KB; Bodey GP; Freireich EJ
Cancer Treat Rep; 1983 Apr; 67(4):389-90. PubMed ID: 6850655
[TBL] [Abstract][Full Text] [Related]
9. [Phase II study of mitoxantrone for hematologic malignancies].
Ueoka H; Ueno K; Yamane T; Toyoda K; Endo H; Nishihara R; Takahashi I; Ohnoshi T; Kitajima K; Kimura I
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2399-402. PubMed ID: 6639101
[TBL] [Abstract][Full Text] [Related]
10. [Phase II study of mitoxantrone].
Tada A; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Adachi K; Nakada H; Okada Y
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1649-54. PubMed ID: 6476838
[TBL] [Abstract][Full Text] [Related]
11. [Response-oriented salvage chemotherapy with mitoxantrone, etoposide and enocitabine for previously treated acute myeloid leukemia. Tohoku Leukemia Study Group].
Chubachi A; Kuriya S; Narigasawa Y; Meguro K; Endo K; Takami H; Sato S; Sasaki H; Shiga T; Maruyama Y
Gan To Kagaku Ryoho; 1995 Dec; 22(14):2101-6. PubMed ID: 8607622
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of mitoxantrone by 24-hour continuous infusion.
Anderson KC; Garnick MB; Meshad MW; Cohen GI; Pegg WJ; Frei E; Israel M; Modest E; Canellos GP
Cancer Treat Rep; 1983 May; 67(5):435-8. PubMed ID: 6850662
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of mitoxantrone in children.
Ungerleider RS; Pratt CB; Vietti TJ; Holcenberg JS; Kamen BA; Glaubiger DL; Cohen LF
Cancer Treat Rep; 1985 Apr; 69(4):403-7. PubMed ID: 3857968
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1538-9. PubMed ID: 6347083
[TBL] [Abstract][Full Text] [Related]
15. [Phase II study of etoposide (VP-16) in the form of intravenous injection for malignant lymphomas and acute leukemias: Hanshin Cooperative Study Group for Hematological Disorders].
Tagawa S; Kitani T; Nagai K; Kanamaru A; Kohsaki M; Masaoka T; Shibata H; Horiuchi A; Tsubaki K; Kawagoe H
Gan No Rinsho; 1987 Jan; 33(1):1-7. PubMed ID: 3469424
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
Moore JO; Olsen GA
Semin Oncol; 1984 Sep; 11(3 Suppl 1):41-6. PubMed ID: 6385265
[TBL] [Abstract][Full Text] [Related]
17. Mitoxantrone and cytosine arabinoside in previously untreated adult patients with acute non-lymphocytic leukemia.
Osman I; Akin U; Ismet A; Meral B; Hamdi A; Haluk K
Haematologia (Budap); 1996; 27(2):93-7. PubMed ID: 14651226
[TBL] [Abstract][Full Text] [Related]
18. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
Warrell RP; Arlin ZA; Kempin SJ; Young CW
Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
[TBL] [Abstract][Full Text] [Related]
19. [A phase II study of mitoxantrone in malignant lymphoma].
Ibuka T; Sasaki T; Imai K; Sakai Y
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2612-7. PubMed ID: 3740861
[TBL] [Abstract][Full Text] [Related]
20. [Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].
Tatsumi N; Yamada K; Ohshima T; Nakamura T; Ohno R; Masaoka T; Kimura I; Kimura K
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2387-95. PubMed ID: 2260876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
